180 related articles for article (PubMed ID: 31926942)
1. ISG15 suppresses translation of ABCC2 via ISGylation of hnRNPA2B1 and enhances drug sensitivity in cisplatin resistant ovarian cancer cells.
Wang JM; Liu BQ; Zhang Q; Hao L; Li C; Yan J; Zhao FY; Qiao HY; Jiang JY; Wang HQ
Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118647. PubMed ID: 31926942
[TBL] [Abstract][Full Text] [Related]
2. ISG15 is downregulated by KLF12 and implicated in maintenance of cancer stem cell-like features in cisplatin-resistant ovarian cancer.
Zhang Q; Wang J; Qiao H; Huyan L; Liu B; Li C; Jiang J; Zhao F; Wang H; Yan J
J Cell Mol Med; 2021 May; 25(9):4395-4407. PubMed ID: 33797839
[TBL] [Abstract][Full Text] [Related]
3. ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome.
Surowiak P; Materna V; Kaplenko I; Spaczynski M; Dolinska-Krajewska B; Gebarowska E; Dietel M; Zabel M; Lage H
Clin Cancer Res; 2006 Dec; 12(23):7149-58. PubMed ID: 17145840
[TBL] [Abstract][Full Text] [Related]
4. RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells.
Materna V; Stege A; Surowiak P; Priebsch A; Lage H
Biochem Biophys Res Commun; 2006 Sep; 348(1):153-7. PubMed ID: 16876126
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
Xu J; Wu J; Fu C; Teng F; Liu S; Dai C; Shen R; Jia X
J Cell Physiol; 2018 Jun; 233(6):5034-5043. PubMed ID: 29219179
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
[TBL] [Abstract][Full Text] [Related]
7. An Approach for the Identification of Proteins Modified with ISG15.
Takeuchi T; Koinuma S; Yokosawa H; Arata Y
Methods Mol Biol; 2019; 1934():235-246. PubMed ID: 31256383
[TBL] [Abstract][Full Text] [Related]
8. MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma.
Guminski AD; Balleine RL; Chiew YE; Webster LR; Tapner M; Farrell GC; Harnett PR; Defazio A
Gynecol Oncol; 2006 Feb; 100(2):239-46. PubMed ID: 16213010
[TBL] [Abstract][Full Text] [Related]
9. UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells.
Falvey CM; O'Donovan TR; El-Mashed S; Nyhan MJ; O'Reilly S; McKenna SL
Oncotarget; 2017 Apr; 8(14):23479-23491. PubMed ID: 28186990
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin.
Xie SM; Fang WY; Liu Z; Wang SX; Li X; Liu TF; Xie WB; Yao KT
J Transl Med; 2008 Oct; 6():55. PubMed ID: 18834541
[TBL] [Abstract][Full Text] [Related]
11. ISG15 in cancer: Beyond ubiquitin-like protein.
Han HG; Moon HW; Jeon YJ
Cancer Lett; 2018 Dec; 438():52-62. PubMed ID: 30213559
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines].
Cheng G; Li Y; Tian F
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):305-8. PubMed ID: 11783113
[TBL] [Abstract][Full Text] [Related]
13. A negative feedback of the HIF-1α pathway via interferon-stimulated gene 15 and ISGylation.
Yeh YH; Yang YC; Hsieh MY; Yeh YC; Li TK
Clin Cancer Res; 2013 Nov; 19(21):5927-39. PubMed ID: 24056783
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid-induced protein ISGylation is dependent on interferon signal transduction.
Dao CT; Luo JK; Zhang DE
Blood Cells Mol Dis; 2006; 36(3):406-13. PubMed ID: 16647867
[TBL] [Abstract][Full Text] [Related]
15. BAG3 deletion suppresses stem cell-like features of pancreatic ductal adenocarcinoma via translational suppression of ISG15.
Li XY; Yan J; Sun J; Li C; Jiang JY; Wang JM; Meng XN; Liang JJ; Wang HQ
Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):819-827. PubMed ID: 30771383
[TBL] [Abstract][Full Text] [Related]
16. The Functional Roles of ISG15/ISGylation in Cancer.
Yuan Y; Qin H; Li H; Shi W; Bao L; Xu S; Yin J; Zheng L
Molecules; 2023 Jan; 28(3):. PubMed ID: 36771004
[TBL] [Abstract][Full Text] [Related]
17. Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat.
To KK; Tong WS; Fu LW
Lung Cancer; 2017 Jan; 103():58-65. PubMed ID: 28024697
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Eag1 Expression by RNA Interference Increases Chemosensitivity to Cisplatin in Ovarian Cancer Cells.
Hui C; Lan Z; Yue-li L; Li-lin H; Li-lin H
Reprod Sci; 2015 Dec; 22(12):1618-26. PubMed ID: 26079730
[TBL] [Abstract][Full Text] [Related]
19. MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1.
Liu Y; Niu Z; Lin X; Tian Y
Cancer Gene Ther; 2017 May; 24(5):208-214. PubMed ID: 28281524
[TBL] [Abstract][Full Text] [Related]
20. Consecutive Inhibition of ISG15 Expression and ISGylation by Cytomegalovirus Regulators.
Kim YJ; Kim ET; Kim YE; Lee MK; Kwon KM; Kim KI; Stamminger T; Ahn JH
PLoS Pathog; 2016 Aug; 12(8):e1005850. PubMed ID: 27564865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
